BIBOLLET-RUCHE FREDERIC ET AL: "The Quality of Chimpanzee T-Cell Activation and Simian Immunodeficiency Virus/Human Immunodeficiency Virus Susceptibility Achieved via Antibody-Mediated T-Cell Receptor/CD3 Stimulation Is a Function of the Anti-CD3 Antibody Isotype", JOURNAL OF VIROLOGY, vol. 82, no. 20, October 2008 (2008-10), pages 10271-10278, XP002600945, ISSN: 0022-538X (B1)

GRAZYNA LIPOWSKA-BHALLA ET AL: "Targeted immunotherapy of cancer with CAR T cells: achievements and challenges", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, vol. 61, no. 7, 22 April 2012 (2012-04-22) , pages 953-962, XP035074376, ISSN: 1432-0851, DOI: 10.1007/S00262-012-1254-0 (B1)

LI BOHUA ET AL: "Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions", IMMUNOLOGY, vol. 116, no. 4, December 2005 (2005-12), pages 487-498, XP002600947, ISSN: 0019-2805 (B1)

PULE M ET AL: "ARTIFICIAL T-CELL RECEPTORS", CYTOTHERAPY, ISIS MEDICAL MEDIA, OXFORD, GB, vol. 5, no. 3, 1 January 2003 (2003-01-01) , pages 211-226, XP008028247, ISSN: 1465-3249, DOI: 10.1080/14653240310001488 (B1)

SADELAIN M ET AL: "The promise and potential pitfalls of chimeric antigen receptors", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 21, no. 2, 1 April 2009 (2009-04-01), pages 215-223, XP026058399, ISSN: 0952-7915, DOI: 10.1016/J.COI.2009.02.009 [retrieved on 2009-03-25] (B1)

SCHLITT H J ET AL: "DIFFERENT ACTIVATION STATES OF HUMAN LYMPHOCYTES AFTER ANTIBODY-MEDIATED STIMULATION VIA CD3 AND THE ALPHA-BETA T CELL RECEPTOR", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, vol. 32, no. 6, 1990, pages 717-726, XP002600946, ISSN: 0300-9475 (B1)

WO-A2-99/60120 (B1)

WO-A-03/020763 (B1)

WO-A1-2004/074322 (B1)

WO-A2-01/93913 (B1)

WO-A2-2005/113595 (B1)

WO-A2-2006/037960 (B1)

US-A1- 2004 253 632 (B1)